PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

RCEM’s winter data reveals much worse picture of A&E waits

The Royal College of Emergency Medicine’s (RCEM) 2019/20 Winter Flow Project has revealed a far worse picture of 12-hour A&E stays than data published by NHS Eng...
Continue Reading →
News

Healx, Boehringer link for rare neurological disease therapy

UK, AI-powered biotech Healx is joining forces with Boehringer Ingelheim to identify indications related to rare neurological diseases. The companies will work tog...
Continue Reading →
News

Private clinic launches UK’s first MRIdian radiotherapy machine

Cancer patients can from today potentially access the UK’s first MRIdian machine, a new radiotherapy treatment said to reduce treatment time and cause fewer side eff...
Continue Reading →
News

SMC green light for rare blood cancer treatment

People in Scotland with the rare blood cancer polycythaemia vera (PV) will soon gain access to a new treatment option on the NHS after cost regulators approved fundi...
Continue Reading →
News

Brits back sharing DNA for research

More than half of Brits (53%) are prepared to share their DNA with a pharmaceutical company to help advance research for drugs and treatments, a survey by KPMG has r...
Continue Reading →
News

EU expands scope of Vertex’ Kalydeco

European regulators have approved expanding the treatment scope of Vertex’ cystic fibrosis (CF) therapy Kalydeco (ivacaftor). The decision allows for the drug’s us...
Continue Reading →
News

New ‘smart pill’ technology reports 100% success rate

Elucid Health has announced that its “Pill Connect” smart pill bottle has reported 100% reliability in a recent survey. The technology, which prompts patients to tak...
Continue Reading →
News

Pharmacist-led interventions may help prevent cardiovascular disease

With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in th...
Continue Reading →
News

Investigational drugs reduce risk of death from Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatmen...
Continue Reading →
News

Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds

Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug discovery, today announced joint success ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026